Please try another search
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Name | Age | Since | Title |
---|---|---|---|
Brian Carrico | 42 | 2018 | President, CEO & Director |
Bradley Mitch Watkins | 49 | 2023 | Independent Chairman |
Beth Keyser | 55 | 2023 | Independent Director |
Kristin A. Ferge | 51 | 2024 | Independent Director |
Christopher Robin Brown | 70 | - | Founder, Director of Innovation & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review